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A B S T R A C T
Mitochondrial fragmentation due to ﬁssion/fusion imbalance has often been linked to mitochondrial dysfunction
and apoptosis in neurodegeneration. Conventionally, it is believed that once mitochondrial morphology shifts
away from its physiological tubular form, mitochondria become defective and downstream apoptotic signaling
pathways are triggered. However, our study shows that beta-amyloid (Aβ) induces morphological changes in
mitochondria where they become granular-shaped and are distinct from fragmented mitochondria in terms of
both morphology and functions. Accumulation of mitochondrial reactive oxygen species triggers granular mi-
tochondria formation, while mitoTEMPO (a mitochondria-targeted superoxide scavenger) restores tubular mi-
tochondrial morphology within Aβ-treated neurons. Interestingly, modulations of mitochondria ﬁssion and fu-
sion by genetic and pharmacological tools attenuated not only the induction of granular mitochondria, but also
mitochondrial superoxide levels in Aβ−treated neurons. Our study shows a reciprocal relationship between
mitochondrial dynamics and reactive oxygen species and provides a new potential therapeutic target at early
stages of neurodegenerative disease pathogenesis.
1. Introduction
Mitochondria are ubiquitous intracellular organelles that regulate
important cellular functions including bioenergetic metabolism, Ca2+
homeostasis and apoptosis. Mitochondrial dysfunction is a prominent
pathological feature in various age-related neurodegenerative diseases
including Alzheimer's disease (AD) [1–6].
The balance between ﬁssion and fusion is required for proper mi-
tochondrial functions due to its involvement in the maintenance of
mitochondrial DNA, segregation of damaged mitochondria by mito-
phagy, distribution and movement of mitochondria within the cell, as
well as regulation of mitochondrial morphology [7–9]. Mitochondrial
fusion is regulated by mitofusins (Mfn1 and Mfn2) and optic atrophy 1
(OPA1) [10–14]; while ﬁssion is mediated by dynamin-related protein
1 (Drp1; also known as DLP-1), mitochondrial ﬁssion 1 protein (Fis-1)
and mitochondrial ﬁssion factor (Mﬀ) [15–19]. Recent studies have
shown that these proteins contribute to the formation of distinct mi-
tochondrial morphologies under diﬀerent cell conditions [20,21]. Oxi-
dative stress has also been shown to induce transient changes in mi-
tochondrial morphology as well as fragmentation of the mitochondrial
network [22–24]. With prolonged and persistent cellular oxidative
damage, interconnected tubular mitochondrial networks are re-
organized as small punctate spheres due to extensive ﬁssion, resulting
in “mitochondrial fragmentation” in apoptosis [25–27].
Mitochondrial network remodelling has been proposed to play an
important role in neurodegeneration [5,28]. β-amyloid peptide (Aβ)
has been shown to promote mitochondrial fragmentation [29–32]. An
imbalance of ﬁssion and fusion proteins has been detected in AD
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patients’ brains as well [30,33]. Furthermore, disruption in the ﬁssion
and fusion balance and mitochondrial traﬃcking have been demon-
strated in various AD transgenic mouse models [34–38]. However, the
precise mechanism underlying mitochondrial fragmentation in AD re-
mains under debate [31,39]. Previous studies often focus on mi-
tochondrial fragmentation as an indicator for cell death and mi-
tochondrial dysfunction. However, the relationship between
mitochondrial morphology and function remains obscure.
Here, we report that Aβ induced unique changes in mitochondrial
morphology, which we refer to as granular mitochondria. Aβ-induced
granular mitochondria maintained functional integrity and were thus
morphologically and functionally distinct from spherical fragmented
mitochondria during apoptosis. Oxidative stress induced by Aβ was
found to impair mitochondrial dynamics, as revealed by simultaneous
photoactivation and ﬂuorescence recovery after photobleaching (SPA-
FRAP) imaging. Notably, we show that mitoTEMPO, the mitochondria-
targeted superoxide scavenger, and both genetic and pharmacological
approaches to inhibit the ﬁssion protein Drp1 could abolish the for-
mation of granular mitochondria by Aβ. Interestingly, attenuation of
granular mitochondria formation by inhibiting ﬁssion could also ame-
liorate Aβ-induced accumulation of reactive oxygen species (ROS). Our
study demonstrates that Aβ induces acute disturbance in mitochondrial
dynamics through induction of oxidative stress, which is independent of
apoptosis. In addition, mitochondria morphology and oxidative stress
reciprocally aﬀects one another in an in vitro model of AD.
2. Materials and methods
2.1. Primary hippocampal culture
Primary culture of hippocampal neurons was prepared from em-
bryonic day 18–19 Sprague-Dawley rats (Laboratory Animal Unit, The
University of Hong Kong, accredited by Association for Assessment and
Accreditation of Laboratory Animal Care International) as previously
described. All experimental protocols involving animals were approved
by the Committee on the Use of Live Animals in Teaching and Research
(CULATR) at LKS Faculty of Medicine, HKU. Brieﬂy, hippocampi were
isolated and mechanically dissociated in ice-cold phosphate buﬀered
saline (Life Technologies) supplemented with glucose (18 mM, Sigma-
Aldrich). Neurons were plated onto poly-L-lysine (25 μg/ml, Sigma-
Aldrich) coated glass-bottomed confocal dishes (SPL Life Science) and
MatTek (MatTek) culture dishes at a density of 1.5×105 cells per dish,
or at 5×104 and 4.5–6×105 cells per well for 12-well and 6-well plates
(Iwaki), respectively. Hippocampal neurons were cultured with
Neurobasal® medium (Life Technologies) supplemented with B-27®
supplement (2%, Life Technologies), GlutaMAX™ (2 mM, Life
Technologies), Penicillin/Streptomycin (100 U and 100 mg/ml, Life
Technologies) and β-mercaptoethanol (10 μM, Sigma-Aldrich) for 7–9
days at 37 °C in a humidiﬁed 5% CO2 atmosphere. 5-Fluoro-2′deox-
yuridine (2 μM, Sigma-Aldrich) was added after one day in culture to
inhibit glial proliferation.
2.2. Transfection
Primary hippocampal neurons seeded on glass-bottomed confocal
dish were transfected on DIV 5–6 for 2–3 h with Lipofectamine 2000
(Life Technologies) according to the manufacturer's protocol. Drug
treatments were performed 24–48 h after transfection. GFP-Mito (mito-
GFP) was purchased from Invitrogen (Life Technologies). DsRed2-Mito
(mito-RFP, Clontech) was a generous gift from Prof. Siu-Kai Kong (The
Chinese University of Hong Kong, Hong Kong). eGFP-BAX and eGFP-
Drp1K38A were gifts from Dr. Zheng Dong (Medical College of Georgia,
USA). pKillerRed-dMito (mito-KillerRed) was purchased from Evrogen
(Evrogen). mito-PAGFP was obtained from Dr. Richard Youle (Addgene
plasmid 23348, Addgene).
2.3. Transfection and transduction
Primary hippocampal neurons seeded on glass-bottomed confocal
dish were transduced with baculovirus-based CellLight® Mitochondria-
GFP, BacMam 2.0 (Invitrogen™) on day 5–6 following seeding. Drug
treatments were performed 24–48 h after transfection.
2.4. Preparation of oligomeric Aβ
Aβ peptides were purchased from Yale University and
ChinaPeptides, and were prepared as previously described [40]. Brieﬂy,
lyophilized Aβ peptide was ﬁrst dissolved in 1, 1, 1, 3, 3, 3-hexaﬂuoro-
2-propanol (Sigma-Aldrich). After evaporation of the peptide solution,
anhydrous DMSO was added to the preparation to achieve the stock
solution. The peptide solution was then sonicated at room temperature
for 30 min. After sonication, Aβ peptides were snap-frozen in liquid
nitrogen, and stored at−80 °C until the day of experiment. Presence of
monomers, dimers, and oligomers was conﬁrmed by Tris-Tricine gel
electrophoresis as shown previously [40]. Aβ peptides were diluted to
the indicated working concentration on the day of the experiment.
2.5. Drug treatments
All drug treatments were performed on DIV6-7. Neurons were
treated with 10 μM oligomeric Aβ for the indicated hours. MitoTEMPO
(2.5 μM; Enzo® Life Sciences), mitochondrial division inhibitor (mdivi-
1, 5 μM; Sigma-Aldrich), and Mitochondrial Fusion Promoter M1
(MFPM1, 5 μM; Sigma-Aldrich) were pre-incubated for 1 h prior to Aβ
treatment. Neurons were incubated with 10 μM carbonyl cyanide p-
triﬂuoro-methoxy-phenyl-hydrazine (FCCP; Sigma-Aldrich) for 2 h to
induce mitochondrial fragmentation. Neurons were treated with H2O2
(50 μM; BDH Chemicals) and rotenone (25 nM; Sigma-Aldrich) for 1 h
to induce oxidative stress.
2.6. Confocal live cell imaging
Primary hippocampal neurons were grown on coverglass-bottom
confocal dishes for confocal live cell imaging. Images were acquired
with a LSM 510 Meta inverted laser-scanning confocal microscope (Carl
Zeiss) using a ×63 1.4 NA Apochromat objective (Carl Zeiss), with an
incubation chamber maintained at 37 °C with 5% CO2 during the ex-
periments. Confocal Z-stack images were acquired at 0.4 µm intervals
for 7 stacks. The excitation wavelengths were 488 nm for GFP; and
543 nm for DsRed2, MitoSOX™ Red, and Rhod-2. TMRE was excited at
800 nm by two-photon excitation (Chameleon, Coherent Inc.).
For light-induced ROS production experiments using mito-
KillerRed, regions of interest were manually deﬁned using the LSM 510
software (Carl Zeiss). To induce light-sensitive ROS production in mi-
tochondria, a small region of one z-plane was irradiated using 100%
power of the 543 nm laser. Frames were then acquired every 15 min
using the 488 nm and 543 nm lasers for 30 min.
For mitochondrial dynamics assays, hippocampal neurons seeded on
coverglass bottomed confocal dishes were co-transfected with mito-RFP
and mito-PAGFP. Regions of interest were manually deﬁned using the
LSM 510 software (Carl Zeiss). Simultaneous photobleaching of mito-
RFP and photoactivation of mito-PAGFP (SPA-FRAP) was performed
using 10% power of the 800 nm laser by two-photon excitation
(Chameleon, Coherent Inc.). After irradiation, images were acquired
every 1 min using the 488 nm and 563 nm laser lines for 30 min. The
diﬀusion rate of mito-PAGFP ﬂuorescence was determined by standard
deviation of whole-cell ﬂuorescence at each time point using the Multi-
measure plugin of Image J (National Institutes of Health, NIH) as pre-
viously described [20]. The ﬂuorescence recovery of mito-RFP in the
irradiated region was measured using Image J (NIH) and normalized
with a non-bleached area.
To study mitochondrial transport in neuronal processes, neurons
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were transfected with mito-RFP. Images were acquired with an ×63 1.4
NA oil Apochromat objective (Carl Zeiss) using a Carl Zeiss Axio
Observer inverted microscope equipped with a Perkin Elmer UltraView®
spinning disk confocal imaging system. Images were taken every 5 s
using the 568 nm laser line of an Argon/Krypton laser (Perkin Elmer)
for 150 cycles (~12 min) using the Metamorph software (Molecular
Devices). Movement of mitochondria were measured using the Imaris
software (Imaris 7.5.1, Bitplane) according to the manufacturer's in-
structions.
Post-acquisition image processing was performed using Adobe
Photoshop (Adobe) and Image J (NIH). Pixel intensities of Rhod-2,
MitoSOX™ Red and TMRE were measured using Image J (NIH) after
background subtraction.
2.7. Quantitative mitochondrial morphometric analysis
For automated morphometric analysis, aspect ratio and circularity
of individual mitochondria were measured using a modiﬁed version of
the mitochondrial morphology plugin of Image J (NIH) developed by
Dagda and colleagues [41]. Volume of mitochondria was measured
using the Particle Analyser plugin for Image J (NIH). All measurements
were calculated from z-axis confocal stacks. To measure individual
mitochondrial length, ﬁve 5 cm × 5 cm grids were randomly selected
from each image and lengths of ﬁve randomly chosen mitochondria
were measured in each grid (Photoshop, Adobe). Individual mi-
tochondria were then sub-divided into three categories according to
their lengths: short (< 0.87 µm), medium-sized (0.87–1.60 µm), and
elongated (> 1.6 µm).
2.8. Quantitative mitochondrial functional analysis
Mitochondrial superoxide production was determined by the mi-
tochondria-speciﬁc superoxide sensor MitoSOX™ Red (Life
Technologies) according to the manufacturer's instructions. Brieﬂy,
hippocampal neurons were incubated with MitoSOX™ Red dye (2.5 μM)
in dark at room temperature for 5 min, followed by washing with pre-
warmed Hanks buﬀered saline solution (HBSS, pH 7.4; Life
Technologies) supplemented with glucose (5.6 mM, Sigma-Aldrich).
Mitochondrial Ca2+ concentrations were measured using the mi-
tochondrial-speciﬁc ﬂuorescent Ca2+ dye Rhod-2 A.M. (Rhod-2) (Life
Technologies). To facilitate mitochondrial localization, hippocampal
neurons were loaded with Rhod-2 (0.5 μM) in HEPES (20 mM)–buﬀered
Neurobasal® medium in dark for 30 min on ice. The dye was then wa-
shed by pre-warmed glucose-supplemented HBSS. Mitochondrial
membrane potential was monitored by the ﬂuorescence intensity of
Tetramethylrhodamine, ethyl ester (TMRE, Life Technologies). Brieﬂy,
TMRE (20 nM) was loaded to the cells and incubated in dark for 5 min
at room temperature, followed by washing with pre-warmed glucose-
supplemented HBSS. ADP/ATP ratio was measured using the ADP/ATP
ratio assay kit (BioVision) according to the manufacturer's protocol.
2.9. SDS-PAGE and Western blotting
Primary hippocampal neurons were lysed in lysis buﬀer (10 mM
Tris at pH 7.4, 100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM NaF,
20 mM Na4P2O7, 1% Triton X-100, 1% glycerol, 0.1% SDS, 0.5%
deoxycholate, 1 mM phenylmethylsulfonyl ﬂuoride) supplemented
with protease inhibitor cocktail (Sigma-Aldrich) and phosphatase in-
hibitor cocktail (Sigma-Aldrich) as previously described [40]. The ex-
tracted proteins were diluted into indicated amounts and separated on
8–12.5% SDS/PAGE and transferred onto polyvinylidene diﬂuoride
(PVDF) blotting membranes (BioRad). The membranes were blocked in
5% non-fat milk (Cell Signaling) dissolved in Tris-buﬀered saline (pH
7.4) containing 0.1% Tween 20 for 1 h at room temperature and probed
with diﬀerent antibodies: anti-DLP1 (1:3000, BD Biosciences), anti-
phospho-Drp1 (Ser 616) (1:1000, Cell Signaling), anti-OPA1 (1:1000,
BD Biosciences), anti-Mfn1 (1:1000, Novus Biologicals), anti-Mfn2
(1:1000, Sigma-Aldrich), anti-VDAC (1:1000, Cell Signaling), anti-
cleaved-caspase-3 (Asp175) (1:1000, Cell Signaling), and anti-β-actin
(1:10,000, Sigma-Aldrich). ECL (GE Healthcare) and Western Bright
ECL (Advansta) were used to develop the ﬁlm. Quantiﬁcation analysis
was performed on scanned ﬁlms using Image J (NIH).
2.10. Mitochondrial fractionation
Mitochondrial fractionation was performed as previously described
[42]. Brieﬂy, neurons were lysed in mitochondrial fractionation lysis
buﬀer (20 mM HEPES at pH 7.5, 250 mM sucrosem, 20 mM KCl,
1.5 mM MgCl2, 1 mM EDTA, 1 mM dithiothreitol and 1 mM phe-
nylmethylsulfonyl ﬂuoride) on ice. The cell lysates were then cen-
trifuged at 600×g for 10 min at 4 °C to remove cell debris. Following
centrifugation, the supernatant was transferred into a new tube and was
centrifuged again at 7000×g for 10 min at 4 °C. The resulting super-
natant and pellet after centrifugation were collected as the cytosolic
fraction and mitochondrial fraction, respectively
2.11. Statistical analysis
All results are represented as mean± S.E.M. for the indicated
number (n) of independent experiments. All experiments were repeated
for at least 3 times. One-way ANOVA test and Kruskal-Wallis test were
used for statistical analysis when appropriate using the GraphPad Prism
software (GraphPad). Tukey's (for one-way ANOVA) and Dunn's (for
Kruskal-Wallis) multiple comparison tests were used as post hoc com-
parisons of individual groups. p values are as indicated in the ﬁgure
legends.
3. Results
3.1. Aβ induces changes in mitochondrial morphology in cultured
hippocampal neurons, which are morphologically distinct from
mitochondrial fragmentation
Primary hippocampal neurons were transfected with mitochondria-
targeted green ﬂuorescent protein (mito-GFP) to visualize individual
mitochondrion using confocal live cell imaging. In control neurons,
mitochondria were mostly thread-like in shape, consistent with pre-
vious studies [43] (Fig. 1a). As early as 1–2 h following exposure to Aβ,
a change in mitochondria morphology was observed as supported by a
signiﬁcant reduction in mitochondrial length when compared with
controls (Fig. 1c). To further validate the changes in mitochondrial
length, neurons were sub-divided into three groups (short, medium,
elongated) according to the mean mitochondrial length [44]. There
were signiﬁcantly higher percentages of transfected neurons with
“short" mitochondria following Aβ treatment (Fig. 1d). To investigate if
the reduction in length was a result of change in shape or in size, the
volume of mitochondria was measured with both total and individual
volume of mitochondria, which were found to be stable when compared
with control (Fig. 1e). Morphometric analysis revealed an approximate
20% reduction in mitochondrial aspect ratio (major axis: minor axis
ratio; a measure of elongation) following exposure to Aβ, suggesting
that Aβ-induced granular mitochondria exhibited a rather ”com-
pressed” and elliptical shape when compared to controls (Fig. 1f).
Furthermore, Aβ-treated mitochondria had a signiﬁcantly higher score
in circularity when compared with controls (Fig. 1g). It is important to
note that there was no signiﬁcant change in the number of mitochon-
dria per neuron when compared with control (Fig. 1h). Western blot
analysis also revealed no signiﬁcant change in the expression level of
the mitochondrial marker voltage-dependent anion channel (VDAC)
following exposure to Aβ (Fig. S2). These results suggest that there was
no mitochondrial loss despite the morphological changes.
To determine whether Aβ-induced granular mitochondria were
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distinct from spherical mitochondria found in apoptosis, potent mi-
tochondrial uncoupler carbonyl cyanide-4-(triﬂuoromethoxy) phe-
nylhydrazone (FCCP) was used to induce fragmentation of the
mitochondrial network. In FCCP-treated neurons, mitochondria showed
a distinct spherical shape which were signiﬁcantly shorter in length
when compared with control (Fig. 1b-d). Notably, there was also a
Fig. 1. Aβ induces morphological changes in mitochondria at early time points (1–6 h) which are morphologically diﬀerent from mitochondrial fragmentation. (a-b) Representative
confocal images of mitochondrial morphology 48 h after transfection with mitochondria-targeted GFP (mito-GFP) in rat primary hippocampal neurons to visualize individual mi-
tochondria. Hippocampal neurons were treated with (a) 10 μM Aβ for the indicated periods (in h) or (b) 10 μM FCCP for 2 h to induce mitochondrial fragmentation (Scale bar: 10 µm).
Images in the bottom row represent magniﬁcation of the boxed areas in the upper row (Scale bar: 2 µm). (c) Percentage of neurons with short (< 0.87 µm), medium-sized (0.87–1.60 µm)
and elongated (> 1.60 µm) mitochondria was quantiﬁed based on the mean mitochondrial length per neuron. **/##p< 0.01, ***/###p<0.001 compared to control, two-way ANOVA
test. (d-h) Statistical quantiﬁcations of mitochondrial morphology for each condition, calculated from z-axis confocal stacks. *p<0.05, ***p< 0.001 compared with control, Kruskal-
Wallis test. ##p< 0.01, ###p<0.001 compared with FCCP, Dunn's multiple comparison post-hoc test. Data represent mean± SEM of at least 11 independent experiments.
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reduction in both volume and number of mitochondria in FCCP-induced
fragmented mitochondria (Fig. 1e & h; p< 0.001), which was not found
to be the case in Aβ−treated neurons. In addition, FCCP-treated frag-
mented mitochondria displayed signiﬁcantly lower aspect ratio and
higher circularity than mitochondria in neurons treated with control
and Aβ (Fig. 1f-g).
It is important to note that although there were signiﬁcant changes
in mitochondrial length, aspect ratio, and circularity in neurons after
exposure to Aβ or FCCP, Aβ-induced granular mitochondria was sig-
niﬁcantly diﬀerent from spherical mitochondria resulting from FCCP
treatment in all shape parameters measured (Fig. 1). While FCCP-in-
duced mitochondrial fragmentation showed a distinct spherical shape
accompanied by a reduction in size, Aβ appeared to induce granular
mitochondria without aﬀecting mitochondria size (Fig. 1). Hence, it is
evident that Aβ-treated granular mitochondria are morphologically
distinct from classic mitochondrial fragmentation. Taken together,
mitochondria changed from a long and interconnected tubular network
to “granular-shaped” which are morphologically distinct from the
classic spherical mitochondria in mitochondrial fragmentation
(Fig. 1 & S1).
To further characterize if Aβ-induced changes in mitochondrial
morphology is a transient process towards fragmentation, neurons were
treated with Aβ for a longer period i.e. 48 h to reveal long-term eﬀects
of Aβ on mitochondrial morphology (Figs. S2–3). Consistent with the
presence of granular mitochondria at 4 h, changes in mitochondrial
morphology in terms of length, aspect ratio and circularity with no
signiﬁcant changes in the total volume, number of mitochondria (Fig.
S3) and mitochondrial content (Fig. S2) were observed when compared
with the control. More importantly, mitochondria following 48 h of Aβ
exposure were also found to be signiﬁcantly diﬀerent from FCCP-in-
duced fragmented spherical mitochondria (Fig. S3b-g). These results
conﬁrmed that Aβ-induced granular mitochondria at early time points
was not a momentary state to fragmentation and indeed persists for a
long period of time in the presence of Aβ.
3.2. Granular mitochondria are functionally distinct from mitochondrial
fragmentation
Mitochondrial fragmentation has often been linked with apoptosis
[26]. Since granular and fragmented mitochondria shared certain de-
grees of morphological similarities i.e. reduction in aspect ratio and
increased circularity, albeit to a diﬀerent extent, we questioned whe-
ther granular mitochondria were also functionally impaired. In re-
sponse to apoptotic stimuli, a reduction of mitochondrial membrane
potential (ΔΨm) causes rupture of the outer mitochondrial membrane,
which subsequently initiates the mitochondria-mediated intrinsic
pathway of apoptosis [45]. Mitochondrial membrane potential was
monitored by the ﬂuorescence intensity of tetramethylrhodamine, ethyl
ester (TMRE). While ΔΨm was signiﬁcantly reduced in FCCP-treated
mitochondria, ΔΨm remained intact within 6 h of Aβ treatment (Fig. 2a-
b). Apart from changes in membrane potential if apoptosis really oc-
curs, induction of apoptosis promotes the translocation of the pro-
apoptotic Bcl-family protein Bax (B-cell lymphoma 2 (Bcl-2)-associated
X protein) from the cytoplasm to mitochondria to form foci with Drp1
and Mfn2 to facilitate ﬁssion [46]. In order to investigate if Bax is as-
sociated with granular mitochondria, hippocampal neurons were co-
transfected with EGFP-Bax and mito-RFP. It was found that following
1–6 h of Aβ treatment, Bax remained in the cytoplasm (Fig. 2d-e). In
addition, there was no signiﬁcant change in the expression levels of the
apoptotic marker, cleaved caspase-3, following exposure to Aβ (Fig. 2f-
g). These data demonstrated that Aβ-induced granular mitochondria
were not associated with the initiation of apoptosis.
Although granular mitochondria were shown to be distinct from
fragmented mitochondria found in apoptosis, we also examined other
aspects of organelle functions in Aβ-induced granular mitochondria
compared with FCCP-treated fragmented mitochondria. Production of
ATP is an important indicator of mitochondrial function. While ATP
production was disturbed in FCCP-treated fragmented mitochondria, as
revealed by a signiﬁcant increase in the ADP/ATP ratio, the ADP/ATP
ratio remained stable after 1–6 h of Aβ treatment (Fig. 2c). This sug-
gests that granular mitochondria maintained their ability to supply
energy for neurons despite changes in morphology. The endoplasmic
reticulum (ER)-mitochondria interaction is essential for proper function
and morphology of the two organelles [47–49]. In addition, our la-
boratory has previously reported collapse of the ER network following
Aβ treatment [40]. Owing to the intimate relationship between the two
organelles, we investigated whether early change of mitochondrial
morphology could cause dissociation of mitochondria from the ER,
thereby aﬀecting mitochondrial function. Primary hippocampal neu-
rons were co-transfected with mito-GFP and ER-targeted RFP (ER-RFP).
No signiﬁcant change in the co-localization level between ER and mi-
tochondria was detected after Aβ treatment, indicating that the inter-
action between the two organelles remained intact despite drastic
changes in mitochondrial morphology (Fig. S4). In contrast, induction
of mitochondrial fragmentation with FCCP substantially reduced the
co-localization between the ER and mitochondria (Fig. S4). In sum, as
opposed to fragmented mitochondria, granular mitochondria main-
tained functional integrity as well as ER-mitochondria tethering, and
are not associated with apoptosis.
3.3. Aβ impairs mitochondrial dynamics without changes in ﬁssion/fusion
protein expression
With no signiﬁcant change in mitochondrial function in the pre-
sence of morphological changes, we went on to study whether changes
in mitochondrial morphology was due to disruptions in ﬁssion and
fusion, the two opposing processes that tightly regulate mitochondrial
morphology [8]. Fission and fusion imbalance has also been implicated
in a number of neurodegenerative diseases including AD [50].
In our study, expression levels of various ﬁssion/fusion-mediating
proteins such as Drp1, OPA1, Mfn1, and Mfn2 all remained stable after
1–6 h of Aβ treatment (Fig. S5). Phosphorylation of Drp1 at Ser616 has
been reported to activate Drp1-mediated ﬁssion and translocation of
Drp1 has also been suggested to be a critical step to initiate ﬁssion [51].
However, no signiﬁcant change in the level of phospho-Drp1Ser616 (Fig.
S5) and the mitochondrial Drp1: cytosolic Drp1 ratio (Fig. S6b & d) was
detected after Aβ treatment. These data suggest that Aβ-induced for-
mation of granular mitochondria does not involve changes in the ex-
pression of common ﬁssion and fusion proteins.
Since expression of ﬁssion and fusion proteins in neurons was not
altered after exposure to Aβ, mitochondrial dynamics was quantiﬁed in
hippocampal neurons co-transfected with mito-RFP and mitochondria-
targeted photoactivable GFP (mito-PAGFP). The region of interest was
simultaneously photobleached and photoactivated by two-photon ex-
citation. Simultaneous photoactivation of mito-PAGFP and ﬂuorescence
recovery after photobleaching (FRAP) imaging of mito-RFP (SPA-FRAP)
allows for a novel two-way measurement of mitochondria dynamics.
Both the diﬀusion rate of mito-PAGFP and ﬂuorescence recovery rate of
mito-RFP were signiﬁcantly slower than that of controls (Fig. 3a-c; p =
0.004 and p = 0.0139, respectively), suggesting that mitochondrial
dynamics was impaired following Aβ treatments at early time points.
Although axonal transport of mitochondria appears to slow down after
Aβ treatment, mitochondria speed was not signiﬁcantly diﬀerent from
control (Fig. 3d).
Therefore, although no changes in the expression of ﬁssion/fusion-
mediating proteins were found, there was a signiﬁcant impairment in
mitochondria dynamics in Aβ treated neurons.
3.4. Accumulation of reactive oxygen species in mitochondria as the
triggering factor of granular mitochondria
Previous studies have implicated the role of oxidative stress in
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Fig. 2. Aβ-induced granular mitochondria maintain functional integrity and are not associated with apoptosis. (a) Representative confocal images of hippocampal neurons loaded with
TMRE, for the determination of mitochondrial membrane potential, and treated with 10 μM Aβ for the indicated periods (in h) or 10 μM FCCP for 2 h (Scale bar: 10 µm). (b) Statistical
quantiﬁcation of mitochondrial membrane potential for each condition, calculated from z-axis confocal stacks. ***p< 0.001 compared with control, Kruskal-Wallis test. Data represent
mean± SEM of 4 independent experiments. (c) Statistical quantiﬁcation of ADP/ATP ratio following 10 μM Aβ for the indicated periods (in h) or 10 μM FCCP for 2 h. *p< 0.05
compared with control, Kruskal-Wallis test. Data represent mean± SEM of 6 independent experiments. (d) Quantiﬁcation of the percentage of neurons with mitochondrial Bax in primary
hippocampal neurons co-transfected with EGFP-Bax and mito-RFP and treated with 10 μM Aβ for the indicated time (h). (e) Representative confocal images of primary hippocampal
neurons co-transfected with mito-RFP and EGFP-Bax and treated with 10 μM Aβ for the indicated periods (in h) or 10 μM FCCP for 2 h (Scale bar: 10 µm). (f-g) Western blot analysis of
cleaved caspase-3 in primary hippocampal neurons treated with 10 μM Aβ for 4 and 48 h. Quantiﬁcation of western blot analysis showed no signiﬁcant diﬀerence in the expression level
of cleaved caspase-3 in neurons treated with 10 μM Aβ for 4 and 48 h (p = 0.1073), Kruskal-Wallis test. Data represent mean± SEM of at least 3 independent experiments.
Fig. 3. Aβ induced increase in mitochondrial super-
oxide, and impairment in mitochondria dynamics.
(a-b) Representative confocal images of hippocampal
neurons loaded with MitoSOX™ Red to detect su-
peroxide concentration in mitochondria, and treated
with 10 μM Aβ for the indicated periods (in h) (Scale
bar: 10 µm). Statistical quantiﬁcations of MitoSOX™
Red ﬂuorescence intensity for each condition, cal-
culated from z-axis confocal stacks, respectively.
***p< 0.001 compared with control; Kruskal-Wallis
test and one way ANOVA test where applicable. Data
represent mean± SEM of 3 independent experi-
ments. (c-e) Quantiﬁcation of mitochondrial dy-
namics by simultaneous photoactivation and ﬂuor-
escence recovery after photobleaching (SPA-FRAP).
Representative confocal images of primary hippo-
campal neurons co-transfected with mito-RFP and
mito-PAGFP and treated with 10 μM Aβ for 4 h
(Scale bar: 10 µm). The region of interest (as shown
by the boxed area) was irradiated with an 800 nm
laser using two-photon excitation to achieve photo-
bleaching of mito-RFP and photoactivation of mito-
PAGFP simultaneously. The irradiation site is shown
in the magniﬁed image. (d-e) Quantiﬁcation of mi-
tochondrial dynamics using SPA-FRAP by measuring
the diﬀusion rate of mito-PAGFP ﬂuorescence and
recovery rate of mito-RFP ﬂuorescence (p = 0.004
and p = 0.0139 respectively). Data represent
mean± SEM of at least 4 independent experiments.
(f) Quantiﬁcation of mitochondria axonal transport
following Aβ treatment. No signiﬁcant change in the
speed of mitochondria was detected following 4 h Aβ
treatment. p = 0.1658 compared with control, Mann
Whitney test. Data represent mean± SEM of 5 in-
dependent experiments.
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Fig. 4. Oxidative stress induces changes in mitochondria morphology comparable to Aβ treatment. (a & d) Representative confocal images of hippocampal neurons expressing mito-GFP
treated with H2O2 and rotenone at the speciﬁed concentrations for 1 h, respectively (Scale bar: 10 µm). Images in the bottom row represent magniﬁcation of the boxed areas in the upper
row (Scale bar: 2 µm). (b-c & e-f) Quantiﬁcation of mitochondria volume and aspect ratio in neurons treated with H2O2 and rotenone, respectively. ***p<0.001 compared with control,
Kruskal-Wallis test, Dunn's multiple comparison post-hoc test. Data represent mean± SEM of at least 3 independent experiments. (g) Representative confocal images of primary hip-
pocampal neurons co-transfected with mito-GFP and mitochondria-targeted photosensitizer mito-KillerRed. The irradiated area is indicated with a square, which is shown in the
magniﬁed image. Representative images from 3 independent experiments are shown.
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mitochondrial dynamics [22,24,29]. Accumulation of ROS has also
been suggested as one of the earliest events in AD pathogenesis [52,53].
Increase in mitochondrial oxidative stress in neurons following ex-
posure to Aβ was supported by a signiﬁcant elevation in ﬂuorescence
intensity of the mitochondria-speciﬁc superoxide indicator MitoSOX™
Red upon 1 h Aβ treatment (Fig. 3e-f). Hence, oxidative stress may be
one of the initiating events in triggering the formation of granular
mitochondria after exposure to Aβ.
Although exposure to Aβ did not induce a change in ﬁssion and
fusion proteins expression, Aβ did induce an increase in oxidative stress
within mitochondria, leading us to examine whether the change in
mitochondrial dynamics was initiated by the presence and accumula-
tion of mitochondrial ROS. The putative oxidative stress-inducing
agents H2O2 and rotenone was applied to primary hippocampal neurons
to investigate the eﬀects of mild oxidative stress on mitochondrial dy-
namics. In hippocampal neurons expressing mito-GFP, we found that
50 μM H2O2 and 25 nM rotenone were able to induce reductions in
aspect ratios without a change in volume (Fig. 4a-f), resulting in
granular mitochondria as observed in Aβ-treated cells. To further con-
ﬁrm the role of oxidative stress on mitochondrial morphology, we in-
duced mitochondria-speciﬁc ROS production using the mitochondria-
targeted photosensitizer KillerRed-dMito (mito-KillerRed). Mito-Kill-
erRed has been shown to induce mitochondria-speciﬁc oxidative stress
upon green light irradiation at 540–580 nm [54,55]. A localized change
in mitochondrial morphology from tubular to granular shape was found
in the region of interest shortly after laser irradiation (Fig. 4g). The
results further conﬁrm that oxidative stress contributes to the changes
in mitochondrial morphology induced by Aβ.
3.5. Reciprocal relationship between mitochondria morphology and
superoxide accumulation
To further conﬁrm if mitochondrial oxidative stress is critical in the
induction of granular mitochondria, neurons were pre-incubated with
the mitochondria-targeted superoxide scavenger, mitoTEMPO, for 1 h
prior to Aβ treatment. MitoTEMPO signiﬁcantly attenuated Aβ-induced
increases in mitochondrial superoxide concentration to a level similar
to control (Fig. 5a-b). Also, mitoTEMPO signiﬁcantly attenuated the
reduction in mitochondrial aspect ratio induced by Aβ (Fig. 5c-d).
These results indicate that mitochondrial superoxide is involved in the
induction of granular mitochondria by Aβ.
Overexpression of the dominant negative mutant Drp1K38A has been
shown to inhibit the GTPase activity of Drp1, hence inhibiting ﬁssion.
Interestingly, overexpression of Drp1K38A also inhibited the morpholo-
gical change induced by Aβ, and no signiﬁcant change in mitochondria
aspect ratio was detected in Aβ-treated neurons when compared with
control (Fig. 5e-f). These results indicate that Aβ-induced granular
mitochondria are likely to be Drp1-dependent. Treatment with mi-
tochondrial division inhibitor 1 (mdivi-1) to inhibit Drp1 polymeriza-
tion and thus attenuate Drp1-dependent mitochondrial ﬁssion [56] was
used to further conﬁrm the role of Drp1 in granular mitochondria for-
mation. Pre-treatment of mdivi-1 abolished the induction of granular
mitochondria by Aβ (Fig. 5c-d). Intriguingly, pre-treatment with mdivi-
1 and overexpression of Drp1K38A also abolished the increase in mi-
tochondrial superoxide concentration induced by Aβ (Fig. 5a-b & g-h).
Similarly, pre-treatment with mitochondrial fusion promoter M1
(MFPM1) [57] also attenuated granular mitochondria formation and
superoxide accumulation in neurons exposed to Aβ (Fig. S7). Therefore,
ROS accumulation results in changes in mitochondrial morphology and
most importantly, modulation of mitochondrial morphology at early
time points can reduce oxidative stress. Most importantly, we have
shown that there is a reciprocal relationship between mitochondria
morphology and oxidative stress in Aβ treated neurons.
4. Discussion
In the present study, we have shown that Aβ induced early mor-
phological change of mitochondria into granular shape which are
morphologically and functionally distinct from spherical mitochondria
seen in classic apoptosis-related mitochondrial fragmentation. Most
importantly, we have shown a reciprocal relationship between ROS and
mitochondrial dynamics at early stages of neurodegeneration.
Mitochondrial ROS is found to disturb mitochondrial dynamics and
play an important role in the induction of granular mitochondria by Aβ.
MitoTEMPO attenuates the induction of mitochondria following Aβ
treatment. Conversely, genetic and pharmacological manipulation of
ﬁssion also diminishes the level of ROS in mitochondria. The induction
of granular mitochondria by Aβ at early time points is likely to be re-
versible and normal tubular mitochondria morphology can be restored
by manipulations of mitochondrial ROS as well as mitochondrial dy-
namics.
Mitochondria are particularly important in neurons owing to the
high-energy demand for neuronal synaptic transmission [58]. Mi-
tochondrial dysfunction, often described as impairment of the electron
transport chain, increased production of ROS and altered mitochondrial
dynamics, is a prominent feature in neurodegeneration [2,3]. In parti-
cular, recent studies have highlighted the crucial role of mitochondrial
dynamics in health and diseases [59–61]. In normal conditions, the
dynamic feature of mitochondria enables them to travel along the axons
and deliver energy to the synapses located at the far ends of a neuron
[62,63]. In response to apoptotic stimuli, as seen in neurodegeneration,
mitochondria undergo fragmentation in which ﬁlamentous mitochon-
dria break into punctate spheres [64].
Traditionally, apoptosis-associated fragmentation of the mitochon-
drial network has been seen as a sign of mitochondrial dysfunction at
late stages of neurodegeneration. However, disturbance in mitochon-
drial dynamics and oxidative damage have been shown as early events
in AD pathogenesis prior to substantial neuronal death [65]. In this
study, we have demonstrated that a change in mitochondrial shape at
early stages of neurodegeneration does not necessarily result in mi-
tochondria dysfunction. Notably, we characterized a unique form of
granular mitochondria induced by Aβ at early time points which is
distinct from Aβ-triggered mitochondrial fragmentation as previously
described (Fig. 1). Despite the change in morphology, ΔΨm and ATP
production remained stable at early time points following Aβ treatment,
implying that granular mitochondria are not functionally defective
(Fig. 2). Furthermore, ER-mitochondria co-localization remained un-
changed (Fig. S4). Thus, Aβ-induced granular mitochondria are mor-
phologically and functionally distinct from classic mitochondrial frag-
mentation in apoptosis. Previous studies have emphasized on the
relationship between mitochondrial fragmentation and organelle dys-
function in neurodegeneration. However, here we show that mi-
tochondria maintain their normal functioning at early stages of disease
despite a change in morphology. Indeed, this unique granular shape
was also found following prolonged Aβ treatment and is not a mere
transition state toward fragmentation (Fig. S3).
The purpose of mitochondrial remodelling into granular shape re-
mains elusive. Recent reports have shown that in stress conditions and
starvation-induced macroautophagy, mitochondria elongate to promote
cell survival and protect themselves from autophagosomal degradation
[20,44]. Furthermore, mitochondria have been shown to display a
“donut-like” toroidal shape during hypoxia-reoxygenation stress [21].
It is possible that diﬀerent cellular stressors at diﬀerent stages of disease
progression induce diﬀerent changes in mitochondria morphology as a
protective mechanism. Interestingly, in primary cultured neurons under
the same treatment condition, those exhibit mitochondrial Bax showed
a signiﬁcantly lower mitochondrial aspect ratio than those with cyto-
solic Bax (Fig. S9). This implies that the transition of mitochondrial
morphology to granular shape might be a possible protective me-
chanism for neurons. Mitochondrial network remodelling to
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irreversible fragmentation as observed in neurodegeneration may not
be a straightforward process.
The morphology of mitochondria is tightly regulated by the balance
between ﬁssion and fusion. Although we found no change in the
expression level of common ﬁssion and fusion proteins (Fig. 3a), Aβ was
conﬁrmed to disrupt mitochondrial dynamics by imaging experiments
(Fig. 3b-d). Traditionally, mitochondrial dynamics are quantiﬁed using
FRAP imaging or photoactivable GFP, independently [20,66,67]. To the
(caption on next page)
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best of our knowledge, this is the ﬁrst study to combine both photo-
activation and FRAP together using SPA-FRAP as a two-way and com-
prehensive measurement of mitochondrial dynamics. As shown by SPA-
FRAP imaging experiments, Aβ reduced the rate of mitochondrial dy-
namics, which contributes to the formation of granular mitochondria
(Fig. 3b-d).
In addition to a change of mitochondrial dynamics, an accumulation
of ROS was found in granular mitochondria (Fig. 4a). In the present
study, oxidative stress in mitochondria was found to be the triggering
factor for the change in mitochondrial shape. Previous studies have
shown that H2O2 and various oxidative stress-inducing agents can in-
duce the classic fragmented morphological changes of mitochondria
[22–24,29]. In our study, we provided evidence that direct application
of oxidative stress inducing agents such as H2O2 and rotenone induced
granular mitochondria, similar to those observed following exposure to
Aβ (Fig. 5a-f). We have also demonstrated that induction of mi-
tochondria-speciﬁc oxidative stress by laser irradiation resulted in an
immediate and localized change in mitochondrial morphology
(Fig. 5g). Our ﬁndings support the induction of granular mitochondria
as a response against increased mitochondrial oxidative stress induced
by Aβ. Notably, our study has highlighted the role of superoxide in
mitochondrial dynamics and AD pathogenesis. Superoxide is a by-pro-
duct from ATP production and is a major cause of oxidative stress.
Overexpression of the mitochondrial antioxidant enzyme superoxide
dismutase (SOD-2) has been shown to reduce hippocampal superoxide
concentration and ameliorate memory deﬁcits in an AD mouse model
[68]. Furthermore, reduction in mitochondrial SOD-2 activity has been
shown to promote AD-like pathology in APP transgenic mice [69]. In
our study, Aβ-induced granular mitochondria can be attenuated by
mitoTEMPO, which demonstrates the crucial role mitochondrial su-
peroxide in maintaining mitochondrial morphology. Therapies tar-
geting mitochondrial superoxide can be a potential pharmacological
target for neurodegenerative diseases including AD.
Interestingly, the induction of granular mitochondria by Aβ can also
be attenuated by both genetic and pharmacological manipulations of
Drp1 activity. Inhibition of the GTPase activity of Drp1 by over-
expression of the dominant negative mutant Drp1K38A and pre-treat-
ment of mdivi-1 abolished the induction of granular mitochondria by
Aβ (Fig. 5c-f). These results suggest that Drp1 plays a role in the in-
duction of granular mitochondria. Intriguingly, pre-incubation of mi-
tochondria-targeted superoxide scavenger mitoTEMPO also inhibited
the change in mitochondrial morphology by Aβ (Fig. 5c-d). The role of
oxidative stress in the modiﬁcation of mitochondrial morphology has
been implicated previously. However, not many studies have in-
vestigated the opposite eﬀect. In line with our ﬁndings, TEMPO-L, a cell
permeable superoxide scavenger, has been shown to prevent mi-
tochondrial fragmentation in mouse coronary endothelial cells isolated
from diabetic mice [70]. Results from our study show that oxidative
stress and mitochondrial morphology reciprocally aﬀect each other.
Application of oxidative stress-inducing agents resulted in the forma-
tion of granular mitochondria while reduction of mitochondrial oxi-
dative stress by mitoTEMPO resulted in the restoration of granular
mitochondria back to tubular-shape (Fig. 5a-f, c-d). This conﬁrms the
crucial role of ROS on the regulation of mitochondrial morphology. In
an opposite condition, we have also shown that by inhibiting Drp1-
dependent ﬁssion, mitochondrial superoxide concentrations would re-
turn to a level similar with controls (Fig. 5a-b). In agree with our re-
sults, a recent study has shown that P110, a selective inhibitor which
blocks Drp1 enzyme activity and Drp1/Fis1 interaction, attenuated
MPP+-induced increases in mitochondrial superoxide levels [71]. An-
other study by Kim et al. also showed that mdivi-1 inhibited Aβ-induced
ROS [72]. Although we did not observe signiﬁcant changes in the ex-
pression level of Drp1 and Drp1 translocation to mitochondria fol-
lowing mitoTEMPO and mdivi-1 treatments (Fig. S6a), it is evident that
mitochondrial dynamics and ROS aﬀect one another. It is not clear if
Drp1 and superoxide directly interact with each other or through sec-
ondary responses to aﬀect mitochondrial morphology in response to an
accumulation of ROS in mitochondria, although previous ﬁndings have
suggested a direct interaction between superoxide and mitochondrial
morphology [70]. Intriguingly, pre-treatment of the fusion promoter
MFPM1 was also found to attenuate the changes in mitochondrial
morphology and ameliorate increased superoxide concentration as in-
duced by Aβ, suggesting mitochondrial elongation by either inhibiting
ﬁssion or promoting fusion can aﬀect mitochondrial ROS. Our study has
provided a new perspective on how manipulations of mitochondrial
dynamics can aﬀect mitochondrial ROS level, and vice versa.
Currently, it is debatable on whether oxidative stress is the cause or
consequence of neurodegeneration. Our study has shown that increased
oxidative stress preceded mitochondrial dysfunction as well as apop-
tosis in an in vitro model of AD (Figs. 2 and 3). ROS accumulation can
be found prior to the formation of classic spherical mitochondria as
seen in apoptosis, and the increase in ROS can be diminished by mi-
tochondria-targeted antioxidant mitoTEMPO and manipulation of mi-
tochondria ﬁssion or fusion by mdivi-1 and MFPM1 (Fig. 5 & S7). Mi-
tochondrial ROS and dynamics have been demonstrated and proposed
as new targets for therapeutic intervention for neurodegeneration
[65,73–75]. Given the mutual relationship between ROS and mi-
tochondrial dynamics, this may provide a novel eﬀective pharmacolo-
gical target for neurodegenerative and other human diseases.
5. Conclusions
Our study showed that at early stages of neurodegeneration, beta-
amyloid (Aβ) induced morphological changes in mitochondria where
they become granular shape which was distinct from the conventional
round and fragmented mitochondria in terms of both morphology and
function. In addition, we demonstrated that accumulation of mi-
tochondrial reactive oxygen species triggered granular mitochondria
formation, while mitoTEMPO (a mitochondria-targeted superoxide
scavenger) restored tubular mitochondrial morphology within Aβ-
treated neurons. Interestingly, modulations of mitochondria ﬁssion and
fusion by genetic and pharmacological means not only attenuated the
induction of granular mitochondria, but also diminished mitochondrial
superoxide levels in Aβ-treated neurons. This study demonstrates a
Fig. 5. Aβ-induced ROS accumulation and change in mitochondria morphology can be restored with mitochondria-targeted superoxide scavenger mitoTEMPO and pharmacological and
genetic manipulations of Drp1 activity. (a) Representative confocal images of primary hippocampal neurons, expressing MitoSOX™ Red, treated with 10 μM Aβ for 4 h and pre-treated
with 2.5 μM mitochondria-targeted superoxide scavenger mitoTEMPO or 5 μM mitochondrial division inhibitor 1 mdivi-1 for 1 h as indicated. (b) Quantiﬁcation of MitoSOX™ Red
ﬂuorescence intensity with or without 10 μM Aβ, mdivi-1, or mitoTEMPO treatment as indicated. ^p< 0.05, ***/###p<0.001, Kruskal-Wallis test and Dunn's multiple comparison post-
hoc test where applicable. Data represent mean± SEM of at least 4 independent experiments (c) Representative confocal images of primary hippocampal neurons, expressing mito-GFP,
treated with 10 μM Aβ for 4 h and pre-treated with mitochondria-targeted superoxide scavenger mitoTEMPO or mitochondrial division inhibitor 1 (mdivi-1) for 1 h as indicated (Scale
bar: 10 µm). Images in the bottom row represent magniﬁcation of the boxed areas in the upper row (Scale bar: 2 µm). (d) Quantiﬁcation of mitochondrial aspect ratio with or without
10 μM Aβ (4 h) treatment and mdivi-1 (1 h) or mitoTEMPO (1 h) pre-treatment as indicated. ***/###/^^^ p< 0.001, one way ANOVA test and Tukey's multiple comparison post-hoc test
where applicable. Data represent mean± SEM of at least 4 independent experiments. (e) Representative confocal images of hippocampal neurons co-transfected with EGFP-Drp1K38A and
mito-RFP and treated with 10 μM Aβ (4 h) (Scale bar: 10 µm.). Boxed area is magniﬁed in the image below. (f) Quantiﬁcation of mitochondrial aspect ratio in primary hippocampal
neurons co-transfected with EGFP-Drp1K38A and mito-RFP and treated with 10 μM Aβ (4 h). Data represent mean± SEM of at least 3 independent experiments. (g) Representative
confocal images of MitoSOX™ Red loaded hippocampal neurons with and without transfection with EGFP-Drp1K38A after treatment with 10 μM Aβ (4 h) (Scale bar: 10 µm.). (h)
Quantiﬁcation of MitoSOX™ Red intensity in 10 μM Aβ (4 h) treated primary hippocampal neurons with and without EGFP-Drp1K38A expression. ***p< 0.001, Kruskal-Wallis test and
Dunn's multiple comparison post-hoc test where applicable. Data represent mean± SEM of at least 3 independent experiments.
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unique reciprocal relationship between mitochondrial dynamics and
reactive oxygen species and provides a new possible therapeutic target
at early stages of neurodegenerative disease pathogenesis.
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